Category Archives: Myocardial Infarction

Myocardial Infarction Drugs Market analysis report has recently added by HealthCare Intelligence Markets which helps to make informed business decisions. Continue reading →

The primary purpose of this study was to examine any potential difference in clinical outcomes between transcarotid artery revascularization performed under local anesthesia compared with general anesthesia by utilizing a large national database. The primary outcome of the study was a composite endpoint of postoperative in-hospital stroke, myocardial infarction and mortality following transcarotid artery revascularization for the index procedure. Continue reading →

Background A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Continue reading →

Myocardial Infarction Drug: This report studies the Myocardial Infarction Drug Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Myocardial Infarction Drug Market analysis segmented by companies, region, type and applications in the report. Market Segment by Companies: BioCardia, Inc., Biscayne Pharmaceuticals, Inc., Capricor Therapeutics, Inc., CellProthera, Celyad SA, Compugen Ltd., CSL Limited, Cynata Therapeutics Limited, FibroGen, Inc., Hemostemix Ltd, Human Stem Cells Institute, HUYA Bioscience International, LLC, Immune Pharmaceuticals Inc., Juventas Therapeutics, Inc., Laboratoires Pierre Fabre SA, Lees Pharmaceutical Holdings Limited, LegoChem Biosciences, Inc, and more Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/myocardial-infarction-drug-global-market-status-trend-report-2013-2023-top-20-countries-data?utm_source=3wnews&utm_medium=39 Myocardial Infarction Drug Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. Continue reading →

The North American Society Leadership drafted a consensus report synthesizing recommendations by cardiovascular societies dealing with the safe reinstatement of elective procedures and tests, halted during the first wave of the novel coronavirus disease 2019 (COVID-19) pandemic. Continue reading →

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Over the last several weeks, hospitals and health systems have focused on the COVID-19 epidemic, preparing and expanding bed capacities for the surge of admissions both in intensive care and medical units. An indirect impact of this has been the reduction in outpatient staffing and resources, with the shifting of staff for inpatient care. Continue reading →

We now have sufficient evidence that people with preexisting medical conditions and the elderly are at higher risk of experiencing severe cases of COVID-19, often leading to death. However, little is known regarding why COVID-19 may peculiarly resemble a heart injury and not just a respiratory problem Continue reading →

Apart from Gianluigi Buffon, there are few goalkeepers in Europe that aremore respected than Real Madrid legend Iker Casillas. Continue reading →

May 20, 2020 08:00 ET | Source: Diffusion Pharmaceuticals Inc. Continue reading →

SINGAPORE: Not adding COVID-19 patientswho died of heart issues instead of the coronavirus to the official death toll is "consistent with international practice", the Ministry of Health (MOH) said. Three confirmedcases have died of heart issues and not of COVID-19since the start of April Continue reading →